AID to overcome the limitations of genomic information

Nature Immunology

Volumn 6, Issue 7, 2005, Pages 655-661

  Honjo, Tasuku ^a   Nagaoka, Hitoshi ^a   Shinkura, Reiko ^a   Muramatsu, Masamichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEAMINASE; DNA; RNA; URACIL;

DEAMINATION; DNA CLEAVAGE; GENE MUTATION; GENE SWITCHING; GENE TARGETING; GENETIC RECOMBINATION; GENOMIC INSTABILITY; GENOMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; DNA REPAIR; GENE REARRANGEMENT; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; RNA EDITING; SOMATIC HYPERMUTATION;

DNA; DNA REPAIR; GENOMIC INSTABILITY; IMMUNOGLOBULIN CLASS SWITCHING; NUCLEOSIDE DEAMINASES; RECOMBINATION, GENETIC; RNA EDITING; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 22144443194     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1218     Document Type: Review

References (102)

1. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431, 931-945 (2004).
2. Gellert, M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71, 101-132 (2002).
3. Neuberger, M.S. & Milstein, C. Somatic hypermutation. Curr. Opin. Immunol. 7, 248-254 (1995).
4. Storb, U. et al. Cis-acting sequences that affect somatic hypermutation of Ig genes. Immunol. Rev. 162, 153-160 (1998).
5. Azuma, T., Motoyama, N., Fields, L.E. & Loh, D.Y. Mutations of the chloramphenicol acetyl transferase transgene driven by the immunoglobulin promoter and intron enhancer. Int. Immunol. 5, 121-130 (1993).
6. Bachl, J. & Olsson, C. Hypermutation targets a green fluorescent protein-encoding transgene in the presence of immunoglobulin enhancers. Eur. J. Immunol. 29, 1383-1389 (1999).
7. Yelamos, J. et al. Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature 376, 225-229 (1995).
8. Rogozin, I.B. & Kolchanov, N.A. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim. Biophys. Acta 1171, 11-18 (1992).
9. Honjo, T., Kinoshita, K. & Muramatsu, M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol. 20, 165-196 (2002).
10. Iwasato, T., Shimizu, A., Honjo, T. & Yamagishi, H. Circular DNA is excised by immunoglobulin class switch recombination. Cell 62, 143-149 (1990).
11. Matsuoka, M., Yoshida, K., Maeda, T., Usuda, S. & Sakano, H. Switch circular DNA formed in cytokine-treated mouse splenocytes: evidence for intramolecular DNA deletion in immunoglobulin class switching. Cell 62, 135-142 (1990).
12. von Schwedler, U., Jack, H.M. & Wabl, M. Circular DNA is a product of the immunoglobulin class switch rearrangement. Nature 345, 452-456 (1990).
13. Muramatsu, M. et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274, 18470-18476 (1999).
14. Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563 (2000).
15. Revy, P. et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102, 565-575 (2000).
16. Petersen-Mahrt, S.K., Harris, R.S. & Neuberger, M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99-103 (2002).
17. Di Noia, J. & Neuberger, M.S. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419, 43-48 (2002).
18. Barreto, V.M., Ramiro, A.R. & Nussenzweig, M.C. Activation-induced deaminase: controversies and open questions. Trends Immunol. 26, 90-96 (2005).
19. Besmer, E., Gourzi, P. & Papavasiliou, F.N. The regulation of somatic hypermutation. Curr. Opin. Immunol. 16, 241-245 (2004).
20. Chaudhuri, J. & Alt, F.W. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4, 541-552 (2004).
21. Larson, E.D. & Maizels, N. Transcription-coupled mutagenesis by the DNA deaminase AID. Genome Biol. 5, 211-213 (2004).
22. Lee, G.S., Brandt, V.L. & Roth, D.B. B cell development leads off with a base hit: dU:dG mismatches in class switching and hypermutation. Mol. Cell 16, 505-508 (2004).
23. Luo, Z., Ronai, D. & Scharff, M.D. The role of activation-induced cytidine deaminase in antibody diversification, immunodeficiency, and B-cell malignancies. J. Allergy Clin. Immunol. 114, 726-735 (2004).
24. Neuberger, M.S. et al. Opinion: Somatic hypermutation at A.T pairs: polymerase error versus dUTP incorporation. Nat. Rev. Immunol. 5, 171-178 (2005).
25. Petersen-Mahrt, S. DNA deamination in immunity. Immunol. Rev. 203, 80-97 (2005).
26. Petersen, S. et al. AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching. Nature 414, 660-665 (2001).
27. Begum, N.A. et al. Uracil DNA glycosylase activity is dispensable for immunoglobulin class switch. Science 305, 1160-1163 (2004).
28. Begum, N.A. et al. De novo protein synthesis is required for activation-induced cytidine deaminase-dependent DNA cleavage in immunoglobulin class switch recombination. Proc. Natl. Acad. Sci. USA 101, 13003-13007 (2004).
29. Nagaoka, H., Ito, S., Muramatsu, M., Nakata, M. & Honjo, T. DNA cleavage in immunoglobulin somatic hypermutation depends on de novo protein synthesis but not on uracil DNA glycosylase. Proc. Natl. Acad. Sci. USA 102, 2022-2027 (2005).
30. Ito, S. et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl. Acad. Sci. USA 101, 1975-1980 (2004).
31. Shinkura, R. et al. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat. Immunol. 5, 707-712 (2004).
32. Ta, V.T. et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat. Immunol. 4, 843-848 (2003).
33. Woo, C.J., Martin, A. & Scharff, M.D. Induction of somatic hypermutation is associated with modifications in immunoglobulin variable region chromatin. Immunity 19,479-489 (2003).
34. Kong, Q. & Maizels, N. DNA breaks in hypermutating immunoglobulin genes: evidence for a break-and-repair pathway of somatic hypermutation. Genetics 158, 369-378 (2001).
35. Bemark, M. & Neuberger, M.S. By-products of immunoglobulin somatic hypermutation. Genes Chromosom. Cancer 38, 32-39 (2003).
36. Doi, T., Kinoshita, K., Ikegawa, M., Muramatsu, M. & Honjo, T. De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination. Proc. Natl. Acad. Sci. USA 100, 2634-2638 (2003).
37. Sawyer, S.L., Emerman, M. & Malik, H.S. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2, 1278-1285 (2004).
38. Conticello, S.G., Thomas, C.J., Petersen-Mahrt, S.K. & Neuberger, M.S. Evolution of the AID/APOBEC family of polynucleotide (deoxy) cytidinedeaminases. Mol. Biol. Evol. 22, 367-377 (2005).
39. Yu, Q. et al. Single-strand specificity of APOBEC3G accounts for minus-strand examination of the HIV genome. Nat. Struct. Mol. Biol. 11, 435-442 (2004).
40. Jarmuz, A. et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296 (2002).
41. Chester, A. et al. The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay. EMBO J. 22, 3971-3982 (2003).
42. Brar, S.S., Watson, M. & Diaz, M. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J. Biol. Chem. 279, 26395-26401 (2004).
43. McBride, K.M., Barreto, V., Ramiro, A.R., Stavropoulos, P. & Nussenzweig, M.C. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J. Exp. Med. 199, 1235-1244 (2004).
44. Pasqualucci, L. et al. Expression of the AID protein in normal and neoplastic B cells. Blood 104, 3318-3325 (2004).
45. Rada, C., Jarvis, J.M. & Milstein, C. AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc. Natl. Acad. Sci. USA 99, 7003-7008 (2002).
46. Barreto, V., Reina-San-Martin, B., Ramiro, A.R., McBride, K.M. & Nussenzweig, M.C. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol. Cell 12, 501-508 (2003).
47. Mehta, A., Kinter, M.T., Sherman, N.E. & Driscoll, D.M. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol. Cell. Biol. 20, 1846-1854 (2000).
48. Ramiro, A.R., Stavropoulos, P., Jankovic, M. & Nussenzweig, M.C. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat. Immunol. 4, 452-456 (2003).
49. Sohail, A., Klapacz, J., Samaranayake, M., Ullah, A. & Bhagwat, A.S. Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res. 31, 2990-2994 (2003).
50. Bransteitter, R., Pham, P., Calabrese, P. & Goodman, M.F. Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase. J. Biol. Chem. 279, 51612-51621 (2004).
51. Bransteitter, R., Pham, P., Scharff, M.D. & Goodman, M.F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA 100, 4102-4107 (2003).
52. Chaudhuri, J., Khuong, C. & Alt, F.W. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 430, 992-998 (2004).
53. Chaudhuri, J. et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422, 726-730 (2003).
54. Dickerson, S.K., Market, E., Besmer, E. & Papavasiliou, F.N. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 197, 1291-1296 (2003).
55. Morgan, H.D., Dean, W., Coker, H.A., Reik, W. & Petersen-Mahrt, S.K. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J. Biol. Chem. 279, 52353-52360 (2004).
56. Pham, P., Bransteitter, R., Petruska, J. & Goodman, M.F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424, 103-107 (2003).
57. Yu, K., Huang, F.T. & Lieber, M.R. DNA substrate length and surrounding sequence affect the activation-induced deaminase activity at cytidine. J. Biol. Chem. 279, 6496-6500 (2004).
58. Poltoratsky, V.P., Wilson, S.H., Kunkel, TA. & Pavlov, Y.I. Recombinogenic phenotype of human activation-induced cytosine deaminase. J. Immunol. 172, 4308-4313 (2004).
59. Petersen-Mahrt, S.K. & Neuberger, M.S. In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1). J. Biol. Chem. 278, 19583-19586 (2003).
60. Harris, R.S., Petersen-Mahrt, S.K. & Neuberger, M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10, 1247-1253 (2002).
61. Rada, C. et al. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12, 1748-1755 (2002).
62. Rada, C., Di Noia, J.M. & Neuberger, M.S. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell 16, 163-171 (2004).
63. Bosma, G.C. et al. DNA-dependent protein kinase activity is not required for immunoglobulin class switching. J. Exp. Med. 196, 1483-1495 (2002).
64. Manis, J.P., Dudley, D., Kaylor, L. & Alt, F.W. IgH class switch recombination to IgG1 in DNA-PKcs-deficient B cells. Immunity 16, 607-617 (2002).
65. Martin, A. et al. Msh2 ATPase activity is essential for somatic hypermutation at a-T basepairs and for efficient class switch recombination. J. Exp. Med. 198, 1171-1178 (2003).
66. Ehrenstein, M.R. & Neuberger, M.S. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J. 18, 3484-3490 (1999).
67. Schrader, C.E., Edelmann, W., Kucherlapati, R. & Stavnezer, J. Reduced isotype switching in splenic B cells from mice deficient in mismatch repair enzymes. J. Exp. Med. 190, 323-330 (1999).
68. Wilson, T.M. et al. MSH2-MSH6 stimulates DNA polymerase η, suggesting a role for A:T mutations in antibody genes. J. Exp. Med. 201, 637-645 (2005).
69. Imai, K. et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4, 1023-1028 (2003).
70. Bross, L. & Jacobs, H. DNA double strand breaks occur independent of AID in hypermutating Ig genes. Clin. Dev. Immunol. 10, 83-89 (2003).
71. Papavasiliou, F.N. & Schatz, D.G. The activation-induced deaminase functions in a postcleavage step of the somatic hypermutation process. J. Exp. Med. 195, 1193-1198 (2002).
72. Nambu, Y. et al. Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 302, 2137-2140 (2003).
73. Wu, X., Geraldes, P., Platt, J.L. & Cascalho, M. The double-edged sword of activation-induced cytidine deaminase. J. Immunol. 174, 934-941 (2005).
74. Martin, A. & Scharff, M.D. AID and mismatch repair in antibody diversification. Nat. Rev. Immunol. 2, 605-614 (2002).
75. Martin, A. & Scharff, M.D. Somatic hypermutation of the AID transgene in B and non-B cells. Proc. Natl. Acad. Sci. USA 99, 12304-12308 (2002).
76. Okazaki, I.M. et al. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197, 1173-1181 (2003).
77. Yoshikawa, K. et al. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296, 2033-2036 (2002).
78. Kotani, A. et al. Overexpressed activation induced cytidine deaminase mutates limited genes with variable base specificity. Proc. Natl. Acad. Sci. USA 102, 4506-4511 (2005).
79. Kodama, M. et al. The PU.1 and NF-EM5 binding motifs in the IgK 3′ enhancer are responsible for directing somatic hypermutations to the intrinsic hotspots in the transgenic VK gene. Int. Immunol, 13, 1415-1422 (2001).
80. Reynaud, C.A. et al. Mismatch repair and immunoglobulin gene hypermutation: did we learn something? Immunol. Today 20, 522-527 (1999).
81. Rada, C., Ehrenstein, M.R., Neuberger, M.S. & Milstein, C. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity, 135-141 (1998).
82. Giusti, A.M. & Manser, T. Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation. J. Exp. Med. 177, 797-809 (1993).
83. Klix, N. et al. Multiple sequences from downstream of the JK cluster can combine to recruit somatic hypermutation to a heterologous, upstream mutation domain, fur. J. Immunol. 28, 317-326 (1998).
84. Michael, N. et al. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19, 235-242 (2003).
85. Reynaud, C.A., Aoufouchi, S., Faili, A. & Weill, J.C. What role for AID: mutator, or assembler of the immunoglobulin mutasome? Nat. Immunol. 4, 631-638 (2003).
86. Wang, C.L., Harper, R.A. & Wabl, M. Genome-wide somatic hypermutation. Proc. Natl. Acad. Sci. USA 101, 7352-7356 (2004).
87. Gordon, M.S., Kanegai, C.M., Doerr, J.R. & Wall, R. Somatic hypermutation of the B cell receptor genes B29 (Igβ, CD79b) and mb1 (Igα, CD79a). Proc. Natl. Acad. Sci. USA 100, 4126-4131 (2003).
88. Pasqualucci, L. et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. USA 95, 11816-11821 (1998).
89. Pasqualucci, L. et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341-346 (2001).
90. Lebecque, S.G. & Gearhart, P.J. Boundaries of somatic mutation in rearranged immunoglobulin genes: 5′ boundary is near the promoter, and 3′ boundary is approximately 1 kb from V(D)J gene. J. Exp. Med. 172, 1717-1727 (1990).
91. Bradney, C. et al. Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J. Biol. Chem. 278, 2370-2376 (2003).
92. Daniels, G.A. & Lieber, M.R. RNA:DNA complex formation upon transcription of immunoglobulin switch regions: implications for the mechanism and regulation of class switch recombination. Nucleic Acids Res. 23, 5006-5011 (1995).
93. Mizuta, R. et al. Molecular visualization of immunoglobulin switch region RNA/DNA complex by atomic force microscope. J. Biol. Chem. 278, 4431-4434 (2003).
94. Reaban, M.E. & Griffin, J.A. Induction of RNA-stabilized DNA conformers by transcription of an immunoglobulin switch region. Nature 348, 342-344 (1990).
95. Tian, M. & Alt, F.W. Transcription-induced cleavage of immunoglobulin switch regions by nucleotide excision repair nucleases in vitro. J. Biol. Chem. 275, 24163-24172 (2000).
96. Yu, K., Chedin, F., Hsieh, C.L., Wilson, T.E. & Lieber, M.R. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat. Immunol. 4, 442-451 (2003).
97. Shinkura, R. et al. The influence of transcriptional orientation on endogenous switch region function. Nat. Immunol. 4, 435-441 (2003).
98. Zarrin, A.A. et al. An evolutionary conserved target motif for immunoglobulin class-switch recombination. Nat. Immunol. 5, 1275-1281 (2004).
99. Tashiro, J., Kinoshita, K. & Honjo, T. Palindromic but not G-rich sequences are targets of class switch recombination. Int. Immunol. 13, 495-505 (2001).
100. Lee, C.G. et al. Quantitative regulation of class switch recombination by switch region transcription. J. Exp. Med. 194, 365-374 (2001).
101. Machida, K. et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc. Natl. Acad. Sci. USA 101, 4262-4267 (2004).
102. He, B., Raab-Traub, N., Casali, P. & Cerutti, A. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J. Immunol. 171, 5215-5224 (2003).